Skip to main content
Abdel-Ghani Azzouqa, MD, Oncology, Rapid City, SD

Abdel-GhaniMustafaAzzouqaMD

Oncology Rapid City, SD

Thoracic Cancer

hematologist and oncologist

Dr. Azzouqa is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

See Dr. Azzouqa's full profile

Already have an account?

  • Office

    353 Fairmont Blvd
    Rapid City, SD 57701
    Phone+1 605-755-2300
    Fax+1 605-755-2310

Education & Training

  • Mayo Clinic College of Medicine and Science (Jacksonville)
    Mayo Clinic College of Medicine and Science (Jacksonville)Fellowship, Hematology and Medical Oncology, 2016 - 2019
  • Cleveland Clinic Foundation
    Cleveland Clinic FoundationResidency, Internal Medicine, 2012 - 2016
  • Jordan University of Science and Technology FOM
    Jordan University of Science and Technology FOMClass of 2011

Certifications & Licensure

  • SD State Medical License
    SD State Medical License Active through 2025
  • FL State Medical License
    FL State Medical License 2016 - 2020
  • OH State Medical License
    OH State Medical License 2013 - 2016
  • American Board of Internal Medicine Internal Medicine
  • American Board of Internal Medicine Hematology
  • American Board of Internal Medicine Medical Oncology

Awards, Honors, & Recognition

  • First Place Winner-The Sarcoma Super Bowl Mayo Clinic Florida
  • Recognition award for Teamwork Above and Beyond Recognition Program

Clinical Trials

Publications & Presentations

PubMed

Journal Articles

  • Reducing Unplanned Medical Oncology Readmissions by Improving Outpatient Care Transitions: A Process Improvement Project at the Cleveland Clinic  
    Montero AJ, Stevenson J, Guthrie AE, Best C, Goodman LM, Shrotriya S, Azzouqa AG, Parala A, Lagman R, Bolwell BJ et al, J Oncol Pract, 1/1/2016

Abstracts/Posters

  • Association of CDKN2A gene alteration with high expression of PD-L1.
    Zhang Y, Marin-Acevedo JA, Azzouqa AG, Manochakian R, Lou Y, Journal of Clinical Oncology, 1/1/2018
  • Gemcitabine in combination with Nab-Paclitaxel for treatment of recurrent ovarian cancer; The Mayo Clinic Florida experience.
    Abdel-Ghani Azzouqa, Gerardo Colon-otero, 27th Annual Mayo Clinic Hem/Onc Reviews, Amelia Island, FL, 1/1/2018
  • Monoclonal Antibody Utilization Characteritics in Patients with Multiple Myeloma.
    Ailawadhi S, Azzouqa A-G, Meghji Z, Jain T, Diehl N, Gebhardt SP, Shah V, Hodge DO, Patel R, Jani P et al, Blood, 1/1/2017
  • Join now to see all

Lectures

  • Impact of time to treatment initiation (TTI) on survival of patients with newly diagnosed non-small cell lung cancer (NSCLC). 
    2019 ASCO Annual Meeting - 6/1/2019
  • Secondary Acute pro myelocytic leukemia. 
    Amelia Island, FL - 1/1/2017
  • Biclonal leukemia. 
    Tampa, FL
  • Join now to see all

Professional Memberships

Other Languages

  • Arabic